Upcoming Seminar:

February 14th, 2019

12:00 PM - 1:00 PM

Speaker: Paul Ewald, PhD

-From: Professor of Biology, University of Louisville

-Title: "Cryptic infectious causation of cancer: new turf for integrating theory, prevention and treatment"

-Location: Moffitt Cancer Center, Stabile Research Building, Ferman Conference Room



Previous Seminars:


  • 1/31 Reinhard C. Laubenbacher, PhD, UConn Health, "Iron metabolism and its role in breast cancer"


  • 9/20 Emil Lou, MD/PhD, Univ. of Minnesota, "Social Dynamics, Networking, and Heterogeneity of Tumor Cells: Deciphering and Intercepting Intercellular Communication in Cancer"

  • 3/30 Olivier Elemento, Meyer Cancer Center, "A cancer precision medicine program driven by multi-omics, analytics and modeling"

  • Travis Gerke, Moffitt Cancer Center, "Estimating the effectiveness of non-randomized treatment regimes with the parametric g-formula"

  • 2/22 Paul Newton, University of Southern California, "Three problems in mathematical oncology"

  • 2/15 Burt P. Kotler, Ben-Gurion University of Negev, "The fundamental laws of ecology and other lessons for helping understanding cancer"

  • 2/8 Jan Poleszczuk, Polish Academy of Sciences, "Non-local effects of radiotherapy and their potential for clinical application: mathematical oncology perspective"

  • 1/25 Shayn Pierce-Cotter, University of Virginia, "Agent-based computational modeling of cells in tissues to predict mechanisms of disease"


  • 11/30 Dr. Kairbaan Hodivala-Dilke, Barts Cancer Institute "Less is better: Using low doses to treat cancer"

  • 9/18 Richard Durrett, Duke University

  • 3/23 Simon Leedham, University of Oxford "Morphogen Signaling in Intestinal Inflammation and Carcinogenesis"

  • 3/10 Kristin R. Swanson, Mayo Clinic "Patient-specific Mathematical Neuro-oncology: Every Patient Deserves Their Own Equation"

  • 3/7 Michalina Janiszewska, Dana-Farber Cancer Institute "Intratumor Heterogeneity, Topology and Therapeutic Resistance

  • 1/12 Elsa Flores, Moffitt Cancer Center "Title to be announced"


  • 12/17 Leah Jonston, USF “Inference for Mechanistic Biological Models

  • 12/1 Claudia Fischbach, Cornell PSOC "Engineering Approaches to Study the Role of ECM Dynamics in the Tumor Microenvironment"

  • 11/14 Sebastien Benzekry, University of Bordeaux "A Few Contributions of Quantitative Modeling in Oncology: Combines Experimental and Modeling Studies"
  • 11/3 Abbas Shirinifard, St. Jude Children's Research Hospital "An Individualized Predictive 3D Model of Tumor Response to Topotecan for a Patient-Derived Orthotopic Xenograft Model of Pediatric Neuroblastoma"
  • 6/17 Andrew Dhawan “Collateral Sensitivity and Fitness Landscapes in ALK-Positive Lung Cancer

  • 5/26 Behnaz Seyfi, UCF “Patient-Specific Model of Human Lung Deformation Using Spatially Dependent Elastic Property

  • 5/24 Arijit Chakravarty, Takeda “The Evolutionary Biology of Cancer: Implications for the Intelligent Design of Anticancer Agents

  • 5/19 John Mulinax, Moffitt “Isolation, Expansion and Characterization of the Immune Infiltrate in Soft Tissue Sarcoma

  • 5/12 Richard Bertram, Florida St “Marrying Mathematical and Experimental Biology

  • 5/5 Tobjorn Lundh, Gothenburg “Competition-Collaboration among Cancer Cell strains

  • 4/21 Andrii Rozhok, UC Denver “Toward an evolutionary model of cancer: insights from in silico modeling and recent experimental findings in the hematopoietic system

  • 4/7 Chris Heery, NCI “Early Stage Immunotherapy Clinical Trials: Correlative Studies to Inform Biologic Understanding

  • 3/29 Marc Ryser, Duke “Stage O Cancer: To treat, or Not to Treat (Right Away), That is the Question

  • 3/17 Ambers Smith, St. Jude “Identifying immune mechanisms of influenzapneumococcal coinfection with model driven experiments

  • 3/3 Eric Stahlberg, NCI “High performance computing in cancer

  • 2/25 Heiko Enderling, Moffitt “Quantitative personalized medicine

  • 1/22 Philip Maini, Oxford “Problem-driven quantitative approaches in cancer

  • 1/21 Sunjune Kim, Moffitt “The immune mechanisms of abscopal effect


  • 12/10 Bonnie Sloane, Wayne State “Spatio-Temporal Modeling and Live-Cell Imaging of 3D Tumor Microenvironment in TAME Chambers

  • 1/7 Hatem Soliman, Moffitt “Breast cancer and immunotherapy

  • 11/19 Benedict Bauer, Max Planck Institute, Ploen “Population Dynamics with Epistatic Interactions and its Applications to Mathematical Models of Cancer

  • 11/5 Vincent Cannataro, U Florida “Quantifying the Burden of Somatic Evolution in the Context of Cancer and Aging

  • 10/22 Etienne Baratchart, “Data-driven modeling of metastatic initiation and tumour-tumour spatial interactions

  • 9/1 Daniel Abate Daga, Moffitt “CAR-T cell therapies. A model

  • 8/17 Jana Gevertz , College of New Jersey “Immunostimulatory Oncolytic Virotherapy with Dendritic Cell Injections: Treatment Dynamics and Optimal Combinations

  • 8/3 Eric Padron, Moffitt “Enabling Precision Medicine: Clonal Reclassification of Myeloid Malignancies

  • 6/18 Peter Johnstone, Moffitt “How Cancer Populations Die

  • 3/5 Rachel Walker, USF “Predicting the future: applications across the sciences

  • 2/19 Tünde Szilágyi “Automatic brain tumor analysis and tumor growth models

  • 2/12 David Robert Grimes, Oxford “Modeling the Role of Oxygen in the Tumour Micro-environment

  • 1/29 Yi Jiang, Georgia State “Let There Be Force: Modeling Cell-Matrix Interactions In Cancer Invasion